about
Highly attenuated Bordetella pertussis strain BPZE1 as a potential live vehicle for delivery of heterologous vaccine candidatesA second-generation anti TB vaccine is long overduePerspectives on the probiotic potential of lactic acid bacteria from African traditional fermented foods and beveragesLive-Attenuated Bacterial Vectors: Tools for Vaccine and Therapeutic Agent DeliveryLive attenuated B. pertussis as a single-dose nasal vaccine against whooping cough.Presence of wild-type and attenuated Salmonella enterica strains in brain tissues following inoculation of mice by different routesHeterologous expression of Brucella abortus GroEL heat-shock protein in Lactococcus lactisImmune response induced by recombinant Mycobacterium bovis BCG producing the cholera toxin B subunit.Oral and nasal DNA vaccines delivered by attenuated Salmonella enterica serovar Typhimurium induce a protective immune response against infectious bronchitis in chickens.The use of live attenuated bacteria as a delivery system for heterologous antigens.Effects of intranasal administration of a leptin-secreting Lactococcus lactis recombinant on food intake, body weight, and immune response of mice.Perspectives for the development of human papillomavirus vaccines and immunotherapy.Targeting diseases with genetically engineered Lactococcus lactis and its course towards medical translation.Development of vaccine delivery vehicles based on lactic acid bacteria.A review of vaccine development and research for industry animals in Korea.Nasal and pulmonary vaccine delivery using particulate carriers.Production of nontypeable Haemophilus influenzae HtrA by recombinant Bordetella pertussis with the use of filamentous hemagglutinin as a carrier.A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers.
P2860
Q24657870-2540417F-5F71-4ECA-AF97-C8C176F53532Q24800887-1F8E7994-A552-4AA4-AC2B-47C98EC43014Q26766691-30640E97-8DEA-4CDD-9ECD-BFC779FD6688Q28084076-0CE82E00-5C02-40AA-8F11-B6AB18E3E344Q30819553-FADB3547-E045-4B23-BF53-487FF11618CCQ33334033-40C6F37F-C228-4B79-9905-13FCB5EA59AEQ34557340-9BF75EDA-7ACA-4C99-B6E9-C3142D409DF5Q34933032-43E5A058-161B-4161-9897-385D05EFAB5FQ35138696-7359E44D-EEF1-4C91-AF38-F6CE4956CF61Q35809240-F1901960-710D-4650-BF67-89BB67E14B4EQ35946659-7C30A160-233F-4309-8A72-F3ABE08227E0Q37658876-009A70E0-1F2F-4358-B307-9E05684267D4Q37825908-5E4E86D1-2673-4FCF-B64A-D1AE81AFB571Q37928954-C3DC2873-B242-408E-AB8A-19305A99B475Q38099839-CBAF2B4F-2855-42FB-8306-57CA7DF4D65DQ38465267-F2EEC893-E5DC-470D-A2C1-891D8785DED2Q40406131-8687EE0E-7C4C-4FD5-9C48-C9173B2738D2Q41860045-9FAADF95-23D6-4470-8F7A-2061A0AE8B5A
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Nasal vaccination using live bacterial vectors.
@ast
Nasal vaccination using live bacterial vectors.
@en
Nasal vaccination using live bacterial vectors.
@nl
type
label
Nasal vaccination using live bacterial vectors.
@ast
Nasal vaccination using live bacterial vectors.
@en
Nasal vaccination using live bacterial vectors.
@nl
prefLabel
Nasal vaccination using live bacterial vectors.
@ast
Nasal vaccination using live bacterial vectors.
@en
Nasal vaccination using live bacterial vectors.
@nl
P2093
P1476
Nasal vaccination using live bacterial vectors.
@en
P2093
P356
10.1016/S0169-409X(01)00168-5
P407
P577
2001-09-01T00:00:00Z